#Newborn Screening Instruments Market Insights

[janetushar1]

Newborn Screening Market to Hit $1433.19 Million by 2032

The global Newborn Screening Market was valued at USD 785.86 Million in 2024 and it is estimated to garner USD 1433.19 Million by 2032 with a registered CAGR of 7.8% during the forecast period 2024 to 2032.

The report throws light on the competitive scenario of the global Newborn Screening Market to know the competition at global levels. Market experts also provided the outline of each leading player of the global Newborn Screening Market for the market, considering the key aspects such as the areas of operation, production, and product portfolio. In addition, the companies in the report are studied based on vital factors such as company size, market share, market growth, revenue, production volume, and profit.

The global Newborn Screening Market is fragmented with various key players. Some of the key players identified across the value chain of the global Newborn Screening Market include PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), Medtronic (Ireland), Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US), Recipe Chemicals+Instruments (Germany), and others. etc. Considering the increasing demand from global markets various new entries are expected in the Newborn Screening Market at regional as well as global levels.

Download Newborn Screening Market Sample Report PDF: https://www.vantagemarketresearch.com/newborn-screening-market-1705/request-sample

Top Competitors:

PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), Medtronic (Ireland), Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US), Recipe Chemicals+Instruments (Germany), and others.

Understanding the Industry's Growth, has released an Updated report on the Newborn Screening Market. The report is mixed with crucial market insights that will support the clients to make the right business decisions. This research will help new players in the global Newborn Screening Market to sort out and study market needs, market size, and competition. The report provides information on the supply and market situation, the competitive situation and the challenges to the market growth, the market opportunities, and the threats faced by the major players.

Regional Analysis

-North America [United States, Canada, Mexico]

-South America [Brazil, Argentina, Columbia, Chile, Peru]

-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

-Middle East & Africa [GCC, North Africa, South Africa]

-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/newborn-screening-market-1705/0

Full Analysis Of The Newborn Screening Market:

Key findings and recommendations point to vital progressive industry trends in the global Newborn Screening Market, empowering players to improve effective long-term policies.

The report makes a full analysis of the factors driving the development of the market.

Analyzing the market opportunities for stakeholders by categorizing the high-growth divisions of the market.

Questions answered in the report

-Who are the top five players in the global Newborn Screening Market?

-How will the global Newborn Screening Market change in the next five years?

-Which product and application will take the lion's share of the global Newborn Screening Market?

-What are the drivers and restraints of the global Newborn Screening Market?

-Which regional market will show the highest growth?

-What will be the CAGR and size of the global Newborn Screening Market during the forecast period?

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/newborn-screening-market-1705

Reasons to Purchase this Newborn Screening Market Report:

-Analysis of the market outlook on current trends and SWOT analysis.

-The geographic and country level is designed to integrate the supply and demand organizations that drive industry growth.

-Newborn Screening Industry dynamics along with market growth opportunities in the coming years.

-Newborn Screening Market value (million USD) and volume (million units) data for each segment and sub-segment.

1 year consulting for analysts along with development data support in Excel. Competitive landscape including market share of major players along with various projects and strategies adopted by players in the last five years.

Market segmentation analysis including qualitative and quantitative analysis including the impact on financial and non-economic aspects.

Complete company profiles that include performance presentations, key financial overviews, current developments, SWOT analyzes and strategies used by major Newborn Screening Market players.

Check Out More Reports

Global Electric Vehicles Battery Market:  Report Forecast by 2032

Global Packaging Automation Solution Market: Report Forecast by 2032

Global Cannabidiol (CBD) Market: Report Forecast by 2032

Global Household Refrigerator Market: Report Forecast by 2032

Global E-Waste Management Market: Report Forecast by 2032

[datalyst]

The Molecular Diagnostics Market: A Deep Dive into Precision Medicine and Technological Advancements

The Molecular Diagnostics Market has emerged as a critical player, driving advancements in precision medicine. This sector's ability to provide specific, reliable, and real-time data at the molecular level has accelerated the development of personalized treatments, enabling clinicians to diagnose diseases earlier and more accurately. From its foundation in genomics to its expanding applications across oncology, infectious diseases, and genetic testing, the molecular diagnostics market is witnessing rapid growth. This blog will explore the molecular diagnostics landscape, its primary technologies, industry growth drivers, and key challenges.

Understanding Molecular Diagnostics

Molecular diagnostics is a field that focuses on analyzing biological markers in the genome and proteome—the individual’s genetic code and how cells express their genes. These diagnostics provide insights into the molecular underpinnings of disease, often involving DNA or RNA detection to understand the health status or predisposition to specific conditions. Unlike traditional diagnostics, molecular diagnostics reveals the root cause at the molecular level, allowing for precise interventions tailored to the patient.

Major Segments in Molecular Diagnostics

The molecular diagnostics market encompasses several segments based on technologies, applications, end-users, and regions.

Technology Key technologies in molecular diagnostics include Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), DNA Microarrays, and In Situ Hybridization (ISH). PCR remains a staple in molecular testing for its simplicity and efficiency, while NGS has unlocked unprecedented possibilities in genomic testing. DNA microarrays, once the go-to technology, continue to play a role in specialized applications, particularly when high-throughput screening is necessary.

Application Applications in molecular diagnostics are vast, with significant focus areas in oncology, infectious disease testing, genetic testing, and pharmacogenomics. Oncology has been one of the fastest-growing applications, given the increasing prevalence of cancers worldwide. In infectious disease testing, molecular diagnostics was instrumental in managing the COVID-19 pandemic, bringing global attention to its capabilities. Genetic testing, which includes prenatal testing and newborn screening, is another vital segment, especially as it enables early disease detection and the potential for preventive care.

End-Users Molecular diagnostics primarily serves hospitals, diagnostic laboratories, academic and research institutes, and even home healthcare setups. Hospitals and diagnostic laboratories account for the highest share due to the need for advanced equipment, high-volume testing, and expert personnel.

The Growth Dynamics of the Molecular Diagnostics Market

The global molecular diagnostics market is projected to grow significantly in the coming years, driven by various factors:

Rising Incidences of Chronic and Infectious Diseases Chronic diseases like cancer, cardiovascular diseases, and diabetes are on the rise globally. Molecular diagnostics enables earlier and more accurate diagnosis, facilitating timely and targeted treatment. Similarly, infectious diseases—such as HIV, hepatitis, tuberculosis, and, more recently, COVID-19—require rapid diagnosis, which molecular diagnostics can deliver with high precision.

Expansion of Precision Medicine Precision medicine, which focuses on tailoring treatment to the individual, has been a major growth driver. Molecular diagnostics enables the identification of patient-specific mutations and disease markers, leading to personalized treatment plans that improve outcomes. The ability to select targeted therapies is particularly significant in cancer treatment, where one-size-fits-all approaches often fall short.

Technological Advancements The molecular diagnostics market has benefited tremendously from technological advancements. The introduction of digital PCR, automated and high-throughput NGS platforms, and enhanced bioinformatics tools has increased testing speed, accuracy, and affordability. Additionally, advancements in artificial intelligence (AI) and machine learning are enabling better data analysis, predictive modeling, and decision-making.

Growing Demand for Point-of-Care Diagnostics Point-of-care (POC) diagnostics allow for on-the-spot testing, often in non-laboratory environments, which can be particularly valuable in managing diseases in remote or underserved areas. As molecular diagnostics advances in miniaturization and automation, point-of-care molecular tests are becoming increasingly feasible, allowing for broader deployment.

Key Technologies Shaping Molecular Diagnostics

Polymerase Chain Reaction (PCR) PCR is a cornerstone of molecular diagnostics, offering simplicity, rapidity, and affordability. Real-time PCR (qPCR) and reverse-transcriptase PCR (RT-PCR) have been widely used, especially in infectious disease testing. The COVID-19 pandemic highlighted PCR's importance, demonstrating its ability to provide accurate and rapid results.

Next-Generation Sequencing (NGS) NGS enables comprehensive genetic analysis, allowing for the simultaneous sequencing of millions of DNA strands. NGS is pivotal in oncology, where it identifies specific mutations associated with cancers. In infectious disease control, NGS helps trace pathogens and track mutations, proving invaluable in managing outbreaks.

CRISPR-based Diagnostics Though still emerging, CRISPR technology is beginning to influence the molecular diagnostics space, especially in infectious disease detection. CRISPR diagnostics leverages gene-editing technology to identify specific DNA or RNA sequences, offering a high level of precision. CRISPR diagnostics are fast, cost-effective, and highly specific, showing promise in point-of-care settings.

Digital PCR Digital PCR has taken PCR a step further by providing higher accuracy and sensitivity, making it ideal for detecting low-abundance DNA or RNA targets. Digital PCR is particularly useful in cancer mutation testing, where detecting rare mutations or quantifying gene expression levels is necessary.

The Role of Bioinformatics in Molecular Diagnostics

As molecular diagnostics involves analyzing large and complex datasets, bioinformatics has become indispensable. Advanced bioinformatics tools enable faster and more accurate analysis of NGS data, aiding in identifying disease markers, understanding drug resistance mechanisms, and providing clinical decision support. With the integration of AI, bioinformatics tools are evolving to predict disease outcomes, identify patient responses to treatment, and suggest targeted therapies, marking a shift toward predictive diagnostics.

Regional Insights: Global Reach of Molecular Diagnostics

The molecular diagnostics market has established a global presence, with key regions contributing uniquely:

North America is the largest market due to high healthcare spending, advanced infrastructure, and early adoption of cutting-edge technologies.

Europe is significant, driven by high incidences of chronic diseases and government support for molecular diagnostics in preventive care.

Asia-Pacific is the fastest-growing region due to rising healthcare awareness, improving infrastructure, and increasing incidences of infectious diseases. China and India are leading this growth, with a particular focus on infectious disease testing.

Latin America and the Middle East & Africa are also developing markets, with gradual adoption of molecular diagnostics.

Challenges and Future Prospects

Despite its growth, the molecular diagnostics market faces challenges, including:

High Costs The initial setup and ongoing operational costs for molecular diagnostics can be prohibitive, particularly in low-resource settings. Although prices have gradually decreased, high-end equipment like NGS systems remains costly.

Regulatory Hurdles Regulatory approval for molecular diagnostics is rigorous, ensuring safety and efficacy. However, the process can be lengthy, especially for innovative technologies like CRISPR and digital PCR.

Skilled Personnel Shortage Running molecular diagnostic tests often requires skilled personnel, limiting the technology's reach in rural and remote areas. Automated and point-of-care devices are gradually addressing this gap, but more workforce training is necessary.

The Road Ahead for Molecular Diagnostics

The future of molecular diagnostics looks promising, with an increasing shift toward preventive and personalized medicine. The integration of digital health tools, AI, and wearable diagnostics is set to enhance the speed and accessibility of molecular testing. Additionally, as sequencing technology becomes more cost-effective, its adoption in routine diagnostics will likely increase, bringing precision medicine to a broader population.

Pharmaceutical and biotech companies are also investing heavily in molecular diagnostics research, especially in companion diagnostics that guide drug development. This partnership between diagnostics and therapeutics will likely yield personalized, effective treatments that reduce side effects and improve patient outcomes.

Conclusion

The molecular diagnostics market is at the forefront of a healthcare transformation, spearheading a shift from reactive to proactive medicine. With its ability to diagnose diseases at the genetic level, tailor treatments to individual patients, and predict disease trajectories, molecular diagnostics is enabling a more personalized and effective healthcare system. The next decade promises even greater advancements, making molecular diagnostics an exciting field poised to redefine how we understand and treat disease.

[omkarpatel]

The Clinical Mass Spectrometry Market is a rapidly growing market owing to increasing applications of mass spectrometry in clinical research and diagnostics

Clinical mass spectrometry finds wide application in clinical research and drug development for disease diagnosis, monitoring disease progression, drug metabolism studies etc. It helps in detection of trace level molecules present in biological samples like blood, urine etc. and provides accurate molecular weight information. The ability of mass spectrometers to perform multitask functions like identification, quantification and structural characterization has increased its demand in clinical settings. The Clinical Mass Spectrometry Market is estimated to be valued at US$ 6.37 Bn in 2023 and is expected to exhibit a CAGR of 26% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends propelling the growth of clinical mass spectrometry market is increasing adoption of LC-MS/MS systems for newborn screening. Newborn screening involves screening of all newborns for certain genetic, endocrine and metabolic disorders which if left untreated can lead to serious health issues or death. Mass spectrometry based newborn screening allows diagnosis of over 50 different disorders in a single sample analysis. Growing incidences of chronic and genetic diseases is driving the adoption of mass spectrometry for newborn screening procedures globally. Additionally, technological advancements improving resolution, throughput and ease of use of mass spectrometers is supporting their increased adoption in clinical research and disease diagnosis. Porter’s Analysis Threat of new entrants: New companies find it difficult to enter into the market as it requires heavy capital investments for R&D, manufacturing and distribution networks. They also face strong competition from existing key players. Bargaining power of buyers: Buyers have moderate bargaining power as there are many established players providing similar clinical mass spectrometry devices. However, highly differentiated products increase switching costs for buyers. Bargaining power of suppliers: Suppliers have low to moderate bargaining power as key components can be substituted and players have multiple sourcing options to avoid dependence on single/few suppliers. Threat of new substitutes: Threat of new substitutes is low as mass spectrometry technology provides unique capabilities for complex proteomic and metabolomic analysis that are difficult to substitute. Competitive rivalry: Intense as key players compete on performance, pricing and aftersales support. SWOT Analysis Strength: Advanced technologies enabling high throughput screening and accurate detection of biomarkers. Wide applications in R&D, clinical diagnosis and treatment monitoring. Weakness: High installation and maintenance costs limiting adoption in low resource settings. Require highly skilled workforce for operation. Opportunity: Growing proteomic and metabolomic research driving demand. Rising incidence of cancers and other chronic diseases creating avenues. Threats: Stringent regulatory approvals delaying new product launches. Economic slowdowns impacting research spending of pharma companies. Key players operating in the clinical mass spectrometry market are SCIEX AB(US), Thermo Fisher Scientific (US), Agilent Technologies (US), Waters Corporation (US), PerkinElmer Inc. (US), Shimadzu Corporation (Japan), Bruker Corporation (US), Analytik Jena (Germany), JEOL Ltd. (Japan), Hiden Analytical (UK), and MKS Instruments (US), among others. Major players are focusing on new product development and geographical expansion to consolidate their market shares.

[alicesara611]

Newborn Screening Instruments Market Size, In-depth Qualitative Insights, Explosive Growth Opportunity, Regional Analysis 2030

The global newborn screening instruments industry is expected to grow from US$ 660 million in 2023 to US$ 1,183.8 million by 2030, at a CAGR of 8.6%. Newborn screening is a process of testing newborns for a variety of genetic and metabolic disorders. These disorders are often not apparent at birth, but can cause serious health problems if not detected and treated early. Newborn screening is a critical part of preventive healthcare for all infants.

Newborn screening instruments are the tools used to perform these tests. There are a variety of different instruments available, each with its own strengths and weaknesses. Some instruments are designed to test a single disorder, while others can test for multiple disorders at once.

Request a Sample copy of this Report! https://absolutemarketresearch.com/Global-Newborn-Screening-Instruments-Market/1302/request-sample

The most common type of newborn screening instrument is the dried blood spot (DBS) card. DBS cards are simple to collect and can be used to screen for a wide range of disorders. To collect a DBS sample, a healthcare professional pricks the baby's heel with a small needle and collects a few drops of blood on a special card. The card is then dried and sent to a laboratory for testing.

Global Newborn Screening Instruments Industry: Growth Factors

Over the course of the projected period, the key growth driver for this market is anticipated to be the rising prevalence of newborn illnesses.

One important aspect that is substantially propelling the growth of the newborn screening devices market is the fast rising global prevalence of newborn diseases. The term "neonatal disorders" encompasses a broad range of congenital, genetic, and metabolic abnormalities that may have long-term detrimental effects on a newborn's general health and development if they are not identified and treated promptly. Effective and thorough newborn screening methods are in greater demand as individuals realize how important it is to identify problems early and take action.

The numbers indicate a worrisome rising trend in the occurrence of diseases in newborns. Studies and data from global health organizations suggest that the prevalence of congenital illnesses and metabolic issues in neonates varies by region and is estimated to be between 2 and 5 percent worldwide. Furthermore, there is an increase in the prevalence of these ailments due to factors such genetic vulnerability, changing lifestyles, and family marriages. The startling increase in the frequency of infant diseases emphasizes how urgently robust newborn screening programs that can accurately detect these problems soon after birth are needed. This would make it possible for medical professionals to start treatments on time, which can significantly enhance patient

Key Takeaways:

The global newborn screening instruments market is expected to grow from US$ 660 million in 2023 to US$ 1,183.8 million by 2030, at a CAGR of 8.6%.

The market is segmented by product into disorder screening, hearing screening, and pulse oximetry screening. The disorder screening segment accounted for the largest share of the market in 2022, and is expected to maintain its dominance during the forecast period.

The market is also segmented by application into hearing screening test, CCHD test, dry blood spot test, and others. The hearing screening test segment is expected to register the fastest growth rate during the forecast period.

North America is expected to account for the largest share of the market in 2023, followed by Europe and Asia Pacific. The Asia Pacific region is expected to register the fastest growth rate during the forecast period.

Global Newborn Screening Instruments Industry Regional Outlook:

North America is expected to account for the largest share of the newborn screening instruments market in 2023. This is due to the high prevalence of congenital diseases in the region, as well as the well-developed healthcare infrastructure.

Europe is expected to be the second-largest market for newborn screening instruments in 2023. This is due to the increasing government support for newborn screening programs, as well as the growing awareness among parents about the importance of early detection of congenital diseases.

Asia Pacific is expected to be the fastest-growing market for newborn screening instruments during the forecast period. This is due to the rising neonatal population, increasing cases of congenital diseases in newborns, and growing consumer awareness.

Key Players:

PerkinElmer, Inc.

Waters Corporation

Natus Medical Incorporated

Ab Sciex LLC

Masimo Corporation

Bio-Rad Laboratories, Inc.

Covidien Plc

Ge Healthcare

Trivitron Healthcare

Agilent Technologies Inc.

Global Newborn Screening Instruments Industry Segmentation:

By Product:

Disorder screening

Hearing screening

Pulse oximetry screening

By Application:

Hearing screening test

CCHD test

Dry blood spot test

Others

By End User:

Hospitals

Clinics

Diagnostic laboratories

Others

[blogaarti]

Newborn Screening Market Analysis, Market Size, In-Depth Insights, Growth and Forecast 2029

The newborn screening test helps in diagnosing rare diseases in newborns, facilitating early treatment. A steady rise in birth rate coupled with rising incidence of serious health disorders among newborns has amplified the demand for newborn screening around the world. Introduction of favourable government programs & legislations is contributing to the demand for newborn screening. Rise in disposable income and provided affordability is making newborn screening more accessible. These aspects, coupled with cutting-edge developments in the health screening domain have propelled significant growth across the global newbron screening market. Besides, parents have become more conscious of the health of their infants further accelerating the pace of market expansion. All these trends hint at the presence of lucrative business possibilities in the global newborn screening market, over the forecast period.  

 For More Industry Insight Read: https://www.fairfieldmarketresearch.com/report/newborn-screening-market

 An Upswing in Health Disorders to Facilitate Newborn Screening Market Expansion

As people are becoming more informed of the health benefits associated with newborn screening, the demand has also mounted at a significant rate. Some of the most prominent newborn screening tests include tests for metabolic disorders, haemoglobin (red blood cell) conditions, hormone (endocrine) disorders, and immune system disorders. Besides, other rare conditions such as Pompe disease, cystic fibrosis, spinal muscular atrophy and X-linked adrenoleukodystrophy are also being significantly diagnosed. An incessant rise in such serious health conditions among infants is creating substantial demand for newborn screening at a global level. Uptick in demand and prevailing serious health disorders are likely to place newborn screening market on a sound growth trajectory.  

 Growing Incidence of Congenital Heart Abnormalities to Create Significant Growth Prospects for Newborn Screening Market

The rising cases of congenital heart abnormalities including tricuspid atresia and pulmonary atresia globally are driving the newborn screening market. Critical congenital heart defects are the most serious congenital heart defects and newborns with critical CHDs require surgery or other treatment within the first year of their life. Therefore, healthcare experts are advocating and supporting the need for more sophisticated screening tools. Furthermore, medical advancements that include ongoing drug discovery, government and non-government organisational initiatives have promoted awareness regarding congenital heart abnormalities. Considering these factors, the global newborn screening market is set to register fruitful outcomes in revenue generation and business expansion.

 North America to Emerge as Key Region Owing to Favourable Reimbursement Policies

The growing prevalence of congenital disorders and mandatory testing in all states are key factors cementing North America as a key revenue generator in the global newborn screening market. In addition to this, the advancements in healthcare infrastructure are projected to bode well for the market. Other factors boosting the growth of the regional market include favourable reimbursement policies and the available newborn screening programs. The cumulative force of these factors is projected to unlock new revenue opportunities for the newborn screening market in North America.

 Leading Market Players

Some of the global players in the newborn screening market include Trivitron Healthcare (India), PerkinElmer (US), Natus Medical (US), Danaher Corporation (US), Demant A/S (Denmark), Bio-Rad Laboratories (US), Chromsystems Instruments & Chemicals GmbH (Germany), and Baebies (US), Medtronic (Ireland), and Recipe Chemicals+Instruments (Germany).

 For More Information Visit: https://www.fairfieldmarketresearch.com/report/newborn-screening-market

 About Us

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

[rohit890]

Newborn Screening Market Key Players, Share, Trends, Sales, Segmentation And Forecast To 2031

Market Overview

The global newborn screening market was valued at USD 1.7 billion in 2021 and it is anticipated to grow up to USD 3.7 billion by 2031, at a CAGR of 8.0% during the forecast period.

Newborn screening identifies conditions that can affect a childs long-term health or survival. This screening technology includes a series of tests essential for timely detection, early diagnosis, and health management to prevent overall disability and avert death of a child. These tests are performed shortly after the baby is born, and detect genetic, developmental, and metabolic disorders in newborn babies. Newborn screening is done by using a few drops of blood from the newborn’s heel, for certain genetic, endocrine, and metabolic disorders, and are tested for hearing loss and critical congenital heart defects (CCHDs) prior to discharge from a hospital or birthing center.

View Detailed Report Description: https://www.globalinsightservices.com/reports/newborn-screening-market/

Market Dynamics

The prevalence of newborn diseases has risen in recent years, prompting providers to raise awareness and support the demand for advanced screening instruments. Hearing, metabolic, and hormonal disorders and critical congenital heart disease are the major newborn disorders; most are treatable if diagnosed early. For instance, according to the US CDC, during 2015–2017, the prevalence of newborn disorders was 34 per 10,000 live births in the US. Approximately 12,900 infants are expected to be identified each year with a disorder. Moreover, according to the same source, the most prevalent disorders are hearing loss (16.5 per 10,000), congenital hypothyroidism (6.0 per 10,000), sickle-cell disease (4.9 per 10,000), and cystic fibrosis (1.8 per 10,000). Such scenario will propel the industry growth.

Several ethical concerns related to prenatal and new-born testing may hamper the market progression. Prenatal and new-born genetic testing raises complex ethical issues further limiting the development of clinical services and implementation of public policy related to access and funding. The use of screening in selective abortion has raised several concerns. The rising occurrence of false results in prenatal and new-born genetic testing might decrease the adoption of genetic testing. For instance, around 5% of women are tested false-positive during prenatal testing for Down syndrome.

Get Free Sample Copy of This Report: https://www.globalinsightservices.com/request-sample/GIS10337

The key players in the market are PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), Medtronic (Ireland), Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US) and Recipe Chemicals+Instruments (Germany), among others.

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: info@globalinsightservices.com

Phone: +1–833–761–1700

[rachel01-zane]

Newborn Screening Instruments Market Revenue Continues to Dominate with CAGR value Globally To 2025

Newborn Screening Instruments Market Revenue Continues to Dominate with CAGR value Globally To 2025

Report Hive Research adds Newborn Screening Instruments Marketreport to its research database. The reported is fairly segmented into market players, regions, applications and their respective types and sub-types. Our researchers have made thorough examination of the market status, based on historical and present market data. They have elaborated the degree of competition faced from major market…

[the-rachana]

Digital Genome Market Is Thriving Worldwide – BioMérieux, Inscripta Inc., Agilent Technologies Inc., F. Hoffmann-La Roche Ltd.

The scientific community has tried to address genetic susceptibility and severity to SARS-CoV-2 infection by combining research efforts using existing genetic databases. Multiomic-based approaches and genome-wide association studies (GWAS) have been employed to uncover biological networks and common variants underlying host-pathogen interactions. Similarly, data derived from genomes, such as polygenic risk scores (PRS), ABO blood groups, and HLA haplotypes, can be potentially used to decipher COVID-19 complications, resistance, and susceptibility.

The global Digital Genome market reached ~US$ 12.1 billion in 2021. The market is expected to witness a CAGR of 10% from 2022 to 2030.

Prenatal genetic screening programs are likely to grow at a significant pace. This is because these programs help expectant mothers identify chromosomal anomalies in their offspring. Moreover, it is anticipated that in the next 10 years, every newborn’s genome would be sequenced and stored in the electronic medical record. Gauging the future market potential of genomics in newborn screening programs, emerging companies like Counsyl and Natera have launched various genetic tests to maintain their competitive edge in the market.

Get a Sample PDF of the Report - https://growthplusreports.com/inquiry/request-sample/digital-genome-market/7910

Key Players

·         BioMérieux

·         GenMark Diagnostics, Inc.

·         Illumina, Inc.

·         Thermo Fisher Scientific

·         NanoString Technologies, Inc.

·         Inscripta Inc.

·         GE Healthcare Genomic Health, Inc.

·         Pacific Bioscience, PerkinElmer Inc.

·         Qiagen Quest Diagnostics

·         Agilent Technologies Inc.

·         Becton, Dickinson and Company

·         F. Hoffmann-La Roche Ltd.

·         Regeneron Pharmaceuticals, Inc.

  By Product Type  

·         Sequence & Analysers Instruments

·         DNA/RNA Analysis kits

·         Sequencing & Analysis Software

·         Sample Preparation Instrument

By Application

·         Microbiology

·         Reproductive & Genetic

·         Transplant & Agriculture

·         Forensics

·         Research & Development

Key Reasons to Purchase:

(1)   To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape.

(2)   Assess the production processes, major issues, and solutions to mitigate the development risk.

(3)   To understand the most affecting driving and restraining forces in the Digital Genome Market and its impact in the global market.

(4)   Learn about the market strategies that are being adopted by leading respective organizations.

(5)   To understand the outlook and prospects for the market.

Key Questions Answered in the Report Include:

(1)   This report gives all the information about the industry analysis, revenue, and overview, of this market.

(2)   What will be the rate of increase in market size and growth rate by the end of the forecast period?

(3)   What are the major global Digital Genome Market trends influencing the development of the market?

(4)   What are the vital results of SWOT analysis of the major players operating in the Digital Genome Market?

(5)   What are the potential growth opportunities and threats faced by Major competitors in the market?

TOC of Digital Genome Market

1 Scope of the Report

1.1 Market Ecosystem

1.2 Geographic Scope

1.3 Timeline Under Consideration

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Digital Genome Market Executive Summary

2.1 World Market Overview

2.1.1 Global Market Size 2022-2030

2.1.2 Market Size CAGR by Region 2020 VS 2028

2.2 Digital Genome Market Segment by Type

2.2.1 Type 1

2.2.2 Type 2

Browse the full report now: https://growthplusreports.com/report/digital-genome-market/7910

About us

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

[clevertimetravelpaper]

Dried Blood Spot Collection Cards Market analysis, scope, market overview. Industry, Company, Key Players, Technology, Trends, Share and Forecast

The market for dried bloodstain collection cards is expected to witness market growth during the forecast period of 2020 to 2027. Data Bridge Market Research analyzes the market to consider a CAGR of 3.10% during the aforementioned forecast period. Dried blood spot cards are used when newborns are screened for congenital disorders or metabolic disorders. The dried blood spot test is a biological swab in which blood samples are dried and blotted on filter paper because it is minimally invasive. These samples are then transported under ambient conditions to an analytical laboratory for the necessary analyses. Applications of dried bloodstain collection cards are systems biology, drug development, forensics,

The increased use of dried blood spots for the diagnosis of autoimmune diseases and infectious diseases is driving the growth of the market. By using dried blood spots, it helps to provide efficient and early diagnosis, facilities such as a convenient alternative to plasma-based tests, easy storage and collection with limited laboratory capacity and stimulates the growth of the market. The advantages are low cost, easy collection and storage and short diagnostic period, high accuracy and others will create new opportunities for the Dried Blood Spot Collection Card market segmented during the period of forecast 2020-2027.

Get Sample PDF of the Report – https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-dried-blood-spot-collection-cards-market

Key Players Covered in Dried Blood Spot Collection Cards Market Report F. Hoffmann-La Roche Ltd, QIAGEN, Shimadzu Scientific Instruments, Eastern Business Forms, Inc, PerkinElmer Inc, Ahlstrom,-Munksjo, Pall Corporation, ARCHIMED Life Science GmbH, CENTOGENE NV, Surgeine Healthcare (India) Pvt, Ltd, Hemaxis, Lipomic Healthcare, Thomas Scientific and Gentegra LLC, among other national and global players. Market share data is available separately for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America . DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

This Dried Blood Spot Collection Card Market report provides details about recent new development, trade regulation, import and export analysis, production analysis, supply chain optimization value, market share, impact of domestic and localized market players, analysis of opportunities in terms of emerging revenue pockets, changes in market regulations, strategic analysis of market growth, market size , category market growth, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.To get more insights on the Data Bridge Market Research Dried Blood Spot Collection Cards Market, contact us for an Analyst Brief, our team will help you make an informed market decision to achieve the growth of the market.

To get more insights into Market Analysis, Browse Research Report Summary @ – https://www.databridgemarketresearch.com/reports/global-dried-blood-spot-collection-cards-market

Global  Dried Blood Spot Collection Cards   Market Scope  and Market Size

The dried bloodstain collection card market is segmented on the basis of application and type of card. The growth among these segments will help you analyze low growth segments within the industries and provide users with valuable market insight and market insights to help them make strategic decisions for identification of major market applications.

Based on application, the dried blood spot collection card market is segmented into newborn screening, infectious disease testing, therapeutic drug monitoring, forensics and others.

Based on card type, the dried bloodstain collection card market is segmented into whatman 903, ahlstrom 226, FTA and others.

Country-Level Analysis of the Global  Dried Blood Spot Collection Cards Market 

The Dried Blood Spot Collection Card market is analyzed and market size insights and trends are provided by country, application and card type as listed above. Countries covered in the Dried Bloodstain Collection Cards market report are US, Canada & Mexico North America, Germany, France, UK, Netherlands , Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia , Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) in Middle East and Africa (MEA) executive,

North America dominates the dried blood spot collection card market owing to high demand for newborn screening, growing number of babies, rise in HIV and other diseases.

Browse Complete TOC at-   https://www.databridgemarketresearch.com/toc/?dbmr=global-dried-blood-spot-collection-cards-market

The country section of the Dried Blood Spot Collection Cards market report also provides individual market impacting factors and regulatory changes in the country market that impact current and future trends in the market. market. Data points such as consumption volumes, production sites and volumes, import and export analysis, price trend analysis, raw material cost, value chain analysis Downstream and Upstream are some of the major indicators used to forecast the market scenario for each country. 

Top Healthcare Report Links:-

About Data Bridge Market Research:

One absolute way to predict what the future holds is to understand today's trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting company with an unparalleled level of resilience and integrated approaches. We are committed to unearthing the best market opportunities and fostering effective information for your business to thrive in the market. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a suite of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Data Bridge Market Research has over 500 analysts working across different industries. We have served over 40% of Fortune 500 companies globally and have a network of over 5,000 clients worldwide. Data Bridge is expert in creating satisfied customers who rely on our services and rely on our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

Contact us:-

Data Bridge Market Research

USA: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:-   corporatesales@databridgemarketresearch.com

[vynzresearchindia]

Global Newborn Screening Market Size, Share and Demand Forecast Report by 2027 | VynZ Research

The Global Newborn Screening Market was value at US$ 0.85 billion in 2020 and it is expected to grow with a strong CAGR of 7.8% during the 2021-2027. In order to achieve the targeted revenue, the market report employs significant and insightful statistics of historical and forecasted data based on growth drivers, challenges and restraints. The report also evaluates the opportunities including technical and government supports for the entrants to joins the market comprehensively.

According to the VynZ Research, the Global Newborn Screening Market size is sub-divided into multiple segments and each segment-wise analysis provides details regarding reasons behind the segment-wise expansion, CAGR, volume, revenue, production, consumption, sales, manufacturing cost, pricing, factors affecting the geographical growth rate.

Get a sample copy of the market analysis report: https://www.vynzresearch.com/healthcare/global-newborn-screening-market/request-sample

The list of major key players of the Global Newborn Screening Market is mentioned in "Competitive insight" along with a thorough overview of their strategies and contribution to the growth plan. Additionally, it provides details on the advantages and disadvantages, institutional growth, cutting-edge discoveries, mergers and acquisitions, expansion plans, footprint, market presence, and product portfolios of the key rivals in the market. Some of the leading market players covered in this global market report are: -

PerkinElmer

Demant A/S

Natus Medical

Bio-Rad Laboratories

Danaher Corporation

Medtronic

Chromsystems Instruments & Chemicals GmbH

Trivitron Healthcare

Baebies

Recipe Chemicals+Instruments

Market segment

This report bifurcates the global market into following categories: -

By Test

Robotic Systems

Services

By Technology

Inspection and Measurement

Object Reconstruction

Projection and Navigation

Reporting and Virtualization

Others

Reason to buy this report

This research report is unbiased and gives the deep insight of market statistics including information on the main market trend and the projected size of the worldwide market based on regional and competitive analyses. The growth of the market has been aided by a number of variables, which are also discussed in this market research report. The report also covers the most innovative and effective techniques for gathering, compiling, estimating, and analyzing market data.

Explore more reports by VynZ Research

Global Wound Dressing Market – Analysis and Forecast (2021-2027)

Global Smart Home Healthcare Market – Analysis and Forecast (2021-2027)

Global Pulse Oximeter Market - Analysis and Forecast (2021-2027)

Global Beauty Devices Market – Analysis and Forecast (2022-2030)

[market-inquiry]

Newborn Screening LC MS Reagent Kits Market Industry in UK Size, Growth, Report Study, Demand, Key Players, and Forecast by 2029

Newborn Screening LC MS Reagent Kits Market Research Report 2022-2029 The Global Newborn Screening LC MS Reagent Kits Market Research Report involves an ideal combination of primary and secondary research with the help of which the experts’ inferences and calculations are derived. Our reports are revised at regular intervals to be able to give recent information to our clients and help them make efficient business decisions. The information provided in the reports is verified in terms of quality and reliability.

The Major Players Covered in this Report: Prominent Players Active in the Market- PerkinElmer Inc., Chromsystems Instruments & Chemicals GmbH, Zivak Technologies, Tech. Dev. Pte. Ltd (SCIEX), RECIPE Chemicals, and Labsystems Diagnostics Oyare some of the key players leading theglobal newborn screening LC-MS reagent kits market.

Get a Sample PDF Report: https://straitsresearch.com/report/Newborn-Screening-LC-MS-Reagent-Kits-market/request-sample

Newborn Screening LC-MS Reagent Kit MarketSegmentation- By Type- Derivatized, Non derivatized, By Sales Channel- Protein Metabolism, Fatty Acid Metabolism, Organic Acid Metabolism, Others

The report specifically highlights the Newborn Screening LC MS Reagent Kits Market Research Report share, company profiles, regional outlook, product portfolio, a record of the recent developments, strategic analysis, key players in the market, sales, distribution chain, manufacturing, production,  new market entrants as well as existing market players, advertising, brand value, popular products, demand and supply, and other important factors related to the Newborn Screening LC MS Reagent Kits Market Research Report to help the new entrants understand the market scenario better.

Important factors like strategic developments, government regulations, Newborn Screening LC MS Reagent Kits Market Research Report analysis, end-users, target audience, distribution network, branding, product portfolio, market share, threats and barriers, growth drivers, latest trends in the industry are also mentioned.

Regional Analysis For Newborn Screening LC MS Reagent Kits Market Research Report:

North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) South America (Brazil, Argentina, Colombia, etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

In this study, the years considered to estimate the market size of the Newborn Screening LC MS Reagent Kits are as follows:

• History Year: 2014-2019 • Base Year: 2019 • Estimated Year: 2020 • Forecast Year 2022 to 2029

The main steps in the investigation process are:

1) The first step in market research is to obtain raw market information from industry experts and direct research analysts using primary and secondary sources.

2) Extracts raw data from these sources to extract valuable insights and analyze them for research purposes.

3) Classify the knowledge gained by qualitative and quantitative data and place it accordingly to make final conclusions.

Key Questions Answered in the Report:

• What is the current scenario of the Global Newborn Screening LC MS Reagent Kits Market Research Report? How is the market going to prosper throughout the next 6 years? • What is the impact of COVID-19 on the market? What are the major steps undertaken by the leading players to mitigate the damage caused by COVID-19? • What are the emerging technologies that are going to profit the market? • What are the historical and the current sizes of the Global Newborn Screening LC MS Reagent Kits Market Research Report? • Which segments are the fastest growing and the largest in the market? What is their market potential? • What are the driving factors contributing to the market growth during the short, medium, and long term? What are the major challenges and shortcomings that the market is likely to face? How can the market solve the challenges? • What are the lucrative opportunities for the key players in the Newborn Screening LC MS Reagent Kits Market Research Report? • Which are the key geographies from the investment perspective? • What are the major strategies adopted by the leading players to expand their market shares? • Who are the distributors, traders, and dealers of the Global Newborn Screening LC MS Reagent Kits Market Research Report? • What are sales, revenue, and price analysis by types and applications of the market?

For More Details On this Report: https://straitsresearch.com/report/Newborn-Screening-LC-MS-Reagent-Kits-market

About Us:

Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enables us to determine greater insights by eliminating the research costs. Moreover, we're continually developing, not only with regards to where we measure, or who we measure but in how our visions can enable you to drive cost-effective growth.

Contact Us:

Company Name: Straits Research Email: sales@straitsresearch.com Phone: +1 646 480 7505 (U.S.) +91 8087085354 (India) +44 208 068 9665 (U.K.)

[technologyreportsworld]

Newborn Screening Market Analysis, Top Key Players, and Industry Statistics, 2021-2028

The report discusses in detail the growth opportunities, challenges, market drivers and restraints, limitations, threats, and demands of the Newborn Screening Market  . The study further assesses the regional market as well as the international market to garner an insight into the scope of the market. The report also offers estimations and predictions about the market segment and sub-segments exhibiting promising growth in the forecast timeline. The report also provides deeper insights into the technological advancements, industrial landscape, and emerging product and technological developments in the Newborn Screening market. It offers fruitful insights into the business sphere to help businesses capitalize on the lucrative growth opportunities.

Keyplayer :

Bio-Rad Laboratories Inc., Agilent Technologies Inc., Trivitron Healthcare, Natus Medical Inc., PerkinElmer Inc., AB Sciex LLC, Covidien Plc, Masimo Corp., GE Healthcare, and Waters Corp., among others.

Get a sample of the report : https://www.emergenresearch.com/request-sample/4

The report further assesses the Newborn Screening market dynamics, market landscape, company profiles, production and manufacturing capacity, year-on-year growth rate, SWOT analysis, and Porter’s Five Forces analysis. It offers in-depth assessment of key companies operating in the market on the basis of their expansion plans, market position, financial standing, and gross profit margins. It also provides information about their current advancements and key market strategies. Furthermore, the report provides a comprehensive overview of the Newborn Screening market along with product portfolio and market performance.

Segmentation :

For the purpose of this report, Emergen Research has segmented the global Newborn Screening Market on the basis of Technology, Product, Application, and region:

Technology Outlook (Revenue, USD Billion; 2017-2027)Tandem Mass Spectrometry Pulse Oximetry Enzyme Based Assay DNA Assay Electrophoresis Others

Product Outlook (Revenue, USD Billion; 2017-2027)Instruments Reagents Assay Kits Others

Application Outlook (Revenue, USD Billion; 2017-2027)Dry Blood Spot Test Critical Congenital Heart Disease (CCHD) Hearing Screen Others

Read More Detail About Newborn Screening Market Report : https://www.emergenresearch.com/industry-report/new-born-screening-market

Key Questions Answered in the Report:

What is the growth rate of the Newborn Screening market? What is the anticipated market valuation of Newborn Screening industry by 2027?

What are the key growth driving and restraining factors of the Newborn Screening market?

Who are the prominent players operating in the market? What are the key strategies adopted by these companies?

What are the key opportunities and growth prospects of the Newborn Screening industry over the forecast period?

Which region is expected to show significant growth in the coming years?

Key points discussed in the report for Global Newborn Screening Market:

Chapter 1: Introduction, market driving force product, Objectives of the Study, and Research Scope of the Newborn Screening market

Chapter 2: Exclusive Summary –vital information of the Newborn Screening Market.

Chapter 3: Market Dynamics- Drivers, Trends, and Challenges of the Newborn Screening Market

Chapter 4: Newborn Screening Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Market segmentation by Type, End-User and Region 2016-2018

Chapter 6: Analysis of the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.

Chapter 7 & 8: Appendix, Methodology and Data Source…Continued

Finally, Newborn Screening Market is a valuable source of guidance for individuals and companies.

Request a discount on the report : https://www.emergenresearch.com/request-discount/4

Key geographical areas:

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Thank you for reading our report. Customization of this report is available in chapter-wise or region-wise sections. Kindly get in touch with us to know more about the report, and our team will provide excellent assistance.

More reports by emergen research @

Waterproofing Systems @ https://www.emergenresearch.com/industry-report/waterproofing-systems-market

Solar LED Street Lighting @ https://www.emergenresearch.com/industry-report/solar-led-street-lighting-market

3D Printing Metal@@ https://www.emergenresearch.com/industry-report/3d-printing-metal-market

Operating Room Integration Systems@  https://www.emergenresearch.com/industry-report/operating-room-integration-systems-market

Small Caliber Ammunition@ https://www.emergenresearch.com/industry-report/small-caliber-ammunition-market

Micro Displays@ https://www.emergenresearch.com/industry-report/micro-displays-market

About Us: At Emergen Research, we believe in advancing with technology. We are a growing market research         and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

[itssashasharma]

Esoteric Testing Market Indicates Impressive Growth Rate In Infectious Disease and Endocrinology Industry

According to the new market research report “Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Genetic Testing), Technology (MS, CLIA, ELISA, PCR), End User (Independent & Reference Laboratories, Hospital Laboratories) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period.

Browse and in-depth TOC on “Esoteric Testing Market”

134 – Tables 47 – Figures 244 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76794708

Growth in the esoteric testing market is primarily driven by the rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis of cancer, and advancements in the personalized medicine are the major factors driving the growth of the esoteric testing market.

The rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis of cancer, and advancements in the personalized medicine are the major factors driving the growth of the market.

In 2020, infectious diseases accounted for the largest share of the Esoteric Testing Market. The genetic testing segment is expected to grow at the highest CAGR during the forecast period.

Based on the type, the market is segmented into infectious disease testing, endocrinology testing, oncology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and other testing. In 2020, the infectious disease testing segment accounted the largest share of the Esoteric Testing Market. The largest share of the segment is attributed to the increasing incidence of infectious diseases, technological innovations in molecular diagnostics, and improving healthcare infrastructure in developing nations. The genetic testing segment is expected to register the highest CAGR during the forecast period. The fastest growth of the genetic testing segment is attributed to the advancements in the sequencing technologies such as NGS and increasing awareness.

CLIA segment account for the largest share of the market in 2020.

Based on technology, Esoteric Testing Market is segmented into chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), mass spectrometry, real-time PCR, flow cytometry, DNA sequencing, and other technologies. CLIA accounted for the largest share of the market in 2020. The large share of this segment can be attributed to its advantages over other testing methods, such as high-performance levels, low detection limits, higher specificity, high signal intensity, and good precision.

Independent & reference laboratories account for the largest share of the Esoteric Testing Market in 2020.

Based on end user, the market is segmented into independent & reference laboratories and hospital-based laboratories. Independent & reference laboratories account for the largest share of the market. The largest share is attributed to the high testing volumes. In addition, the ongoing automation, and digitalization of diagnostic laboratories, growing number of accredited laboratories, significant reimbursement coverage, and the competitive benefits offered by these providers are pushing the growth of the segment.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76794708

North America was the largest regional market for the Esoteric Testing Market in 2020

The market is segmented into four major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America was the largest regional market for market in 2020. The large share of the North American market can be attributed to the increasing per capita healthcare expenditure, presence of the leading market players, increasing use of rapid diagnostics, expanding geriatric population, and advancing precision medicine in the region.

However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. Emerging APAC economies such as China and India are expected to see significant growth due their advancing healthcare infrastructure, increasing penetration of cutting-edge clinical laboratories, and expanding geriatric population are the major factors driving the growth of this market.

The global Esoteric Testing Market is consolidated. The prominent players operating in this market include Labcorp (US), Quest Diagnostics (US) and OPKO Health Inc. (US).

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Newborn Screening Market by Product (Instrument, Consumables), Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Molecular, Pulse Oximetry), End User (Hospitals) – Global Forecast to 2026

https://www.marketsandmarkets.com/Market-Reports/newborn-screening-market-141676244.html

Immunofluorescence Assay Market by Product (Reagent, Instruments, Antibodies, Kits, Consumables & Accessories), Type (Direct, Indirect), Disease (Infectious Disease, Other Diseases), End User (Contract Research Organizations) – Global Forecast to 2026

https://www.marketsandmarkets.com/Market-Reports/immunofluorescence-assay-market-255585571.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email: sales@marketsandmarkets.com Content Source:  https://www.marketsandmarkets.com/PressReleases/esoteric-testing.asp Research Insight: https://www.marketsandmarkets.com/ResearchInsight/esoteric-testing-market.asp

[daisyri-me]

Newborn Screening Market by Manufacturers, Regions, Type and Application, Forecast to 2022

The global Newborn Screening Market is anticipated to grow significantly in the forecast period due to increasing need for the detection of metabolic, genetic, and developmental disorders in infants. Newborn screening is the test conducted for infants shortly after their birth. Early detection and treatment reduces or prevents the risk of physical and intellectual disabilities, and also life threatening disorders in infants.

Get Exclusive Free Sample Copy Of This Report @ https://www.millioninsights.com/industry-reports/newborn-screening-market/request-sample

The test is generally undertaken by national or state government bodies and is divided into three parts, namely blood test, hearing test, and CCHD (critical congenital heart disease) screen. For blood test, few blood drops are taken from the infant’s heels and is sent to the lab for analysis. For hearing test, either a tiny microphone or earpiece in the baby’s ear, or electrodes are placed on the infant’s head while it is asleep or quiet. In CCHD screening, a tiny soft sensor attached with oximeter machine is placed on the infant’s skin. This machine measures the infant’s oxygen level in the hands and foot.

Major factors attributing to the growth of the newborn screening market include increasing government initiatives towards baby health and public health benefits in the developed economies, availability of laboratory sciences and enhanced technologies, increasing investment or innovations in the domain, growing cases of neonatal disorders among infants, and increasing awareness for hereditary disorders in babies. However, strict regulations in few economies that delay hospitalization and low availability of technologically enhancement in tests and instruments are hampering the newborn screening industry growth.

Increasing government support to the manufacturers for the development of fresh screening tests that comply with the regulations is trending in the newborn screening market. Increasing government regulations for better infant health is an opportunity for the industry players to improve their industry presence and expand product portfolio.

ArcherDX, one of the leading players is predicted to expand its product portfolio with screening tests for the identification of genetic variants drivers associated to various disorders like cystic fibrosis, fragile X syndrome, and spinal muscular atrophy. The player has acquired Baby Genes, the genetic personalized medicine laboratory, which will run under ArcherDX Clinical Services. The acquisition will include Baby Gene’s genetics laboratory, in Golden, Colorado, and the infant screening panel that investigates above 100 genes. The player will also continue to rule the current newborn and carrier screening solutions with Baby Genes brand.

The major players operating in the domain include Trivitron Healthcare, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Masimo Corporation, Bio-Rad Laboratories, PerkinElmer Inc., General Electric Healthcare, Natus Medical Incorporated, and Waters Corporation.

Browse Full Research Report With TOC on https://www.millioninsights.com/industry-reports/newborn-screening-market

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email:ryan@millioninsights.com